Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions

Infection and Immunity

Volumn 78, Issue 4, 2010, Pages 1601-1609

  Oliveira, Débora L ^a   Freire de Lima, Célio G ^a   Nosanchuk, Joshua D ^b   Casadevall, Arturo ^b   Rodrigues, Marcio L ^a   Nimrichter, Leonardo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; INTERLEUKIN 10; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; HUMAN; INCUBATION TIME; MACROPHAGE; MAMMAL; MEMBRANE VESICLE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CRYPTOCOCCUS NEOFORMANS; CYTOPLASM; GENE EXPRESSION; INTERLEUKIN-10; MACROPHAGES; MICE; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE; SECRETORY VESICLES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77950223615     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01171-09     Document Type: Article

References (82)

1. Albuquerque, P. C., E. S. Nakayasu, M. L. Rodrigues, S. Frases, A. Casadevall, R. M. Zancope-Oliveira, I. C. Almeida, and J. D. Nosanchuk. 2008. Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cell Microbiol. 10:1695-1710.
2. Alvarez, M., and A. Casadevall. 2007. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol. 8:16.
3. Alvarez, M., and A. Casadevall. 2006. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16:2161-2165.
4. Beauvais, A., M. Monod, J. Wyniger, J. P. Debeaupuis, E. Grouzmann, N. Brakch, J. Svab, A. G. Hovanessian, and J. P. Latge. 1997. Dipeptidylpeptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans. Infect. Immun. 65:3042-3047.
5. Bomberger, J. M., D. P. Maceachran, B. A. Coutermarsh, S. Ye, G. A. O'Toole, and B. A. Stanton. 2009. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382.
6. Bulmer, G. S., and M. D. Sans. 1968. Cryptococcus neoformans. III. Inhibition of phagocytosis. J. Bacteriol. 95:5-8.
7. Casadevall, A., J. D. Nosanchuk, P. Williamson, and M. L. Rodrigues. 2009. Vesicular transport across the fungal cell wall. Trends Microbiol. 17:158-162.
8. Casadevall, A., and L. Pirofski. 2001. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184:337-344.
9. Chaffin, W. L., J. L. Lopez-Ribot, M. Casanova, D. Gozalbo, and J. P. Martinez. 1998. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:130-180.
10. Chaka, W., J. Scharringa, A. F. Verheul, J. Verhoef, A. G. Van Strijp, and I. M. Hoepelman. 1995. Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry. Clin. Diagn. Lab Immunol. 2:753-759.
11. Chiapello, L. S., J. L. Baronetti, M. P. Aoki, S. Gea, H. Rubinstein, and D. T. Masih. 2004. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology 113:392-400.
12. Cox, G. M., J. Mukherjee, G. T. Cole, A. Casadevall, and J. R. Perfect. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:443-448.
13. Datta, K., A. Lees, and L. A. Pirofski. 2008. Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. Clin. Vaccine Immunol. 15:1176-1187.
14. De Jesus, M., A. M. Nicola, M. L. Rodrigues, G. Janbon, and A. Casadevall. 2009. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot. Cell 8:96-103.
15. Del Poeta, M. 2004. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot. Cell 3:1067-1075.
16. Djordjevic, J. T., M. Del Poeta, T. C. Sorrell, K. M. Turner, and L. C. Wright. 2005. Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor. Biochem. J. 389:803-812.
17. Dong, Z. M., and J. W. Murphy. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65:557-563.
18. Douwes, J., P. Versloot, A. Hollander, D. Heederik, and G. Doekes. 1995. Influence of various dust sampling and extraction methods on the measurement of airborne endotoxin. Appl. Environ. Microbiol. 61:1763-1769.
19. Eigenheer, R. A., Y. Jin Lee, E. Blumwald, B. S. Phinney, and A. Gelli. 2007. Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans. FEMS Yeast Res. 7:499-510.
20. Eisenman, H. C., S. Frases, A. M. Nicola, M. L. Rodrigues, and A. Casadevall. 2009. Vesicle-associated melanization in Cryptococcus neoformans. Microbiology 155:3860-3867.
21. Ellerbroek, P. M., D. J. Lefeber, R. van Veghel, J. Scharringa, E. Brouwer, G. J. Gerwig, G. Janbon, A. I. Hoepelman, and F. E. Coenjaerts. 2004. O-Acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J. Immunol. 173:7513-7520.
22. Ellerbroek, P. M., L. H. Ulfman, A. I. Hoepelman, and F. E. Coenjaerts. 2004. Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endothelium. Cell Microbiol. 6:581-592.
23. Feldmesser, M., S. Tucker, and A. Casadevall. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278.
24. Ghosn, E. E., M. Russo, and S. R. Almeida. 2006. Nitric oxide-dependent killing of Cryptococcus neoformans by B-1-derived mononuclear phagocyte. J. Leukoc. Biol. 80:36-44.
25. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
26. Hao, S., T. Moyana, and J. Xiang. 2007. Cancer immunotherapy by exosome-based vaccines. Cancer Biother. Radiopharm. 22:692-703.
27. Jacobson, E. S. 2000. Pathogenic roles for fungal melanins. Clin. Microbiol. Rev. 13:708-717.
28. Jacobson, E. S., D. J. Ayers, A. C. Harrell, and C. C. Nicholas. 1982. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J. Bacteriol. 150:1292-1296.
29. Kadurugamuwa, J. L., and T. J. Beveridge. 1995. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177:3998-4008.
30. Kawakami, K., Y. Koguchi, M. H. Qureshi, S. Yara, Y. Kinjo, K. Uezu, and A. Saito. 2000. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Microbiol. Immunol. 44:1043-1050.
31. Kawakami, K., M. H. Qureshi, Y. Koguchi, T. Zhang, H. Okamura, M. Kurimoto, and A. Saito. 1999. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. Cell Immunol. 193:9-16.
32. Kozel, T. R., B. Highison, and C. J. Stratton. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect. Immun. 43:574-579.
33. Kozel, T. R., and G. S. Pfrommer. 1986. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect. Immun. 52:1-5.
34. Kozel, T. R., G. S. Pfrommer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev. Infect. Dis. 10(Suppl. 2):S436-S439.
35. Kozel, T. R., M. A. Wilson, G. S. Pfrommer, and A. M. Schlageter. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
36. Kuehn, M. J., and N. C. Kesty. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19:2645-2655.
37. Latgé, J. P., H. Kobayashi, J. P. Debeaupuis, M. Diaquin, J. Sarfati, J. M. Wieruszeski, E. Parra, J. P. Bouchara, and B. Fournet. 1994. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect. Immun. 62:5424-5433.
38. Lee, E. Y., D. Y. Choi, D. K. Kim, J. W. Kim, J. O. Park, S. Kim, S. H. Kim, D. M. Desiderio, Y. K. Kim, K. P. Kim, and Y. S. Gho. 2009. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 9:5425-5436.
39. Liu, L., R. P. Tewari, and P. R. Williamson. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
40. Ma, H., J. E. Croudace, D. A. Lammas, and R. C. May. 2007. Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol. 8:15.
41. Ma, H., J. E. Croudace, D. A. Lammas, and R. C. May. 2006. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16:2156-2160.
42. + T lymphocyte responses. Cell Immunol. 222:116-125.
43. Miller, M. F., and T. G. Mitchell. 1991. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59:24-28.
44. Mirshafiey, A., D. T. Ngoc Dzung, J. W. Murphy, M. R. Khorramizadeh, F. Saadat, F. Mehrabian, and P. Larsson. 2004. Tolerability and anti-inflammatory effects of glucuronoxylomannan in collagen-induced arthritis. Scand. J. Immunol. 60:226-232.
45. Monari, C., F. Bistoni, A. Casadevall, E. Pericolini, D. Pietrella, T. R. Kozel, and A. Vecchiarelli. 2005. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J. Infect. Dis. 191:127-137.
46. Monari, C., A. Casadevall, C. Retini, F. Baldelli, F. Bistoni, and A. Vecchiarelli. 1999. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans. AIDS 13:653-660.
47. Monari, C., T. R. Kozel, F. Bistoni, and A. Vecchiarelli. 2002. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans. Infect. Immun. 70:3363-3370.
48. Monari, C., E. Pericolini, G. Bistoni, A. Casadevall, T. R. Kozel, and A. Vecchiarelli. 2005. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of Fas ligand in macrophages. J. Immunol. 174:3461-3468.
49. Monod, M., K. Jaton-Ogay, and U. Reichard. 1999. Aspergillus fumigatus-secreted proteases as antigenic molecules and virulence factors. Contrib. Microbiol. 2:182-192.
50. Mukherjee, S., M. Feldmesser, and A. Casadevall. 1996. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173:1222-1231.
51. Murphy, J. W., F. Schafer, A. Casadevall, and A. Adesina. 1998. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans. Infect. Immun. 66:2632-2639.
52. Naslund, P. K., W. C. Miller, and D. L. Granger. 1995. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect. Immun. 63:1298-1304.
53. Nichols, K. L., S. K. Bauman, F. B. Schafer, and J. W. Murphy. 2002. Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans. Infect. Immun. 70:591-600.
54. Nicola, A. M., A. Casadevall, and D. L. Goldman. 2008. Fungal killing by mammalian phagocytic cells. Curr. Opin. Microbiol. 11:313-317.
55. Nicola, A. M., S. Frases, and A. Casadevall. 2009. Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule. Eukaryot. Cell 8:1373-1380.
56. Nosanchuk, J. D., L. Nimrichter, A. Casadevall, and M. L. Rodrigues. 2008. A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis. Commun. Integr. Biol. 1:37-39.
57. Oliveira, D. L., L. Nimrichter, K. Miranda, S. Frases, K. F. Faull, A. Casadevall, and M. L. Rodrigues. 2009. Cryptococcus neoformans cryoimmuno-electronmicroscopy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronxylomannan. Fungal Genet. Biol. 46:956-963.
58. Panepinto, J., K. Komperda, S. Frases, Y. D. Park, J. T. Djordjevic, A. Casadevall, and P. R. Williamson. 2009. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol. Microbiol. 71:1165-1176.
59. Pietrella, D., C. Monari, C. Retini, B. Palazzetti, T. R. Kozel, and A. Vecchiarelli. 1998. Cryptococcus neoformans and Candida albicans regulate CD4 expression on human monocytes. J. Infect. Dis. 178:1464-1471.
60. Puccia, R., S. Schenkman, P. A. Gorin, and L. R. Travassos. 1986. Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect. Immun. 53:199-206.
61. Reiss, E., M. Huppert, and R. Cherniak. 1985. Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Curr. Top. Med. Mycol. 1:172-207.
62. Rodrigues, M. L., M. Alvarez, F. L. Fonseca, and A. Casadevall. 2008. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot. Cell 7:602-609.
63. Rodrigues, M. L., C. S. Alviano, and L. R. Travassos. 1999. Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms. Microbes Infect. 1:293-301.
64. Rodrigues, M. L., E. S. Nakayasu, D. L. Oliveira, L. Nimrichter, J. D. Nosanchuk, I. C. Almeida, and A. Casadevall. 2008. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot. Cell 7:58-67.
65. Rodrigues, M. L., L. Nimrichter, D. L. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell 6:48-59.
66. Rossi, G. R., L. A. Cervi, M. M. Garcia, L. S. Chiapello, D. A. Sastre, and D. T. Masih. 1999. Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. Clin. Immunol. 90:256-265.
67. Schaller, M., M. Bein, H. C. Korting, S. Baur, G. Hamm, M. Monod, S. Beinhauer, and B. Hube. 2003. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect. Immun. 71:3227-3234.
68. Syme, R. M., J. C. Spurrell, E. K. Amankwah, F. H. Green, and C. H. Mody. 2002. Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect. Immun. 70:5972-5981.
69. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9:581-593.
70. Tissi, L., M. Puliti, F. Bistoni, P. Mosci, T. R. Kozel, and A. Vecchiarelli. 2004. Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis. Infect. Immun. 72:6367-6372.
71. Tucker, S. C., and A. Casadevall. 2002. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. USA 99:3165-3170.
72. Vecchiarelli, A., D. Pietrella, P. Lupo, F. Bistoni, D. C. McFadden, and A. Casadevall. 2003. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J. Leukoc. Biol. 74:370-378.
73. Vecchiarelli, A., C. Retini, D. Pietrella, C. Monari, C. Tascini, T. Beccari, and T. R. Kozel. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect. Immun. 63:2919-2923.
74. Villena, S. N., R. O. Pinheiro, C. S. Pinheiro, M. P. Nunes, C. M. Takiya, G. A. DosReis, J. O. Previato, L. Mendonca-Previato, and C. G. Freire-de-Lima. 2008. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol. 10:1274-1285.
75. Vyas, K. A., H. V. Patel, A. A. Vyas, and R. L. Schnaar. 2001. Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol. Chem. 382:241-250.
76. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
77. Wozniak, K. L., and S. M. Levitz. 2008. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect. Immun. 76:4764-4771.
78. Xiao, G., A. Miyazato, K. Inden, K. Nakamura, K. Shiratori, K. Nakagawa, T. Miyazawa, K. Suzuki, M. Kaku, and K. Kawakami. 2008. Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharides. Microbiol. Immunol. 52:171-179.
79. Yauch, L. E., J. S. Lam, and S. M. Levitz. 2006. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2:e120.
80. Zaragoza, O., C. J. Chrisman, M. V. Castelli, S. Frases, M. Cuenca-Estrella, J. L. Rodriguez-Tudela, and A. Casadevall. 2008. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol. 10:2043-2057.
81. Zaragoza, O., M. L. Rodrigues, M. De Jesus, S. Frases, E. Dadachova, and A. Casadevall. 2009. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 68:133-216.
82. Zaragoza, O., C. P. Taborda, and A. Casadevall. 2003. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur. J. Immunol. 33:1957-1967.